POSTER SESSION II
Monday, February 28, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
97
PTEN and Phosphorylated S6 Expression in Clinically insignificant Prostate Adenocarcinoma: Correlation with ERG Fusion Status.
(734)
R Albadine, A Chaux, J Hicks, A De Marzo, GJ Netto - Johns Hopkins Medical Institution, Baltimore
ERG Protein IHC Expression as an Alternative Methodology for Evaluation of ERG Fusion Status in Prostate Adenocarcinoma.
(903)
GJ Netto, R Albadine, A Chaux, A Toubaji, J Hicks, A Meeker, AM Demarzo - Johns Hopkins Medical Institution, baltimore
Evaluation of TMPRSS2-ERG Fusion Protein in Prostate Cancer Pathogenesis across Continents.
(830)
R Henshall-Powell, C Yu, R Bremer, IA Sesterhenn, D Tacha - Biocare Medical, Concord, CA; AFIP, Washington, DC
ERG Oncoprotein Overexpression in Matched Primary and Metastatic Prostate Adenocarcinomas.
(825)
B Gurel, H Fedor, JL Hicks, AM De Marzo - Johns Hopkins University School of Medicine, Baltimore
ERG-Mediated Repression of HPGD in Prostate Tumorigenesis.
(893)
A Mohamed, T Sreenath, S-H Tan, C Sun, S Shaheduzzaman, Y Hu, G Petrovics, Y Chen, D McLeod, A Dobi, S Srivastava, I Sesterhenn - Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Rockville, MD; Armed Forces Institute of Pathology, Washington, DC; Walter Reed Army Medical Center, Washington, DC
Comparison of Immunohistochemistry with FISH for Detection of TMPRSS2-ERG Rearrangement in Prostate Cancers in African American and Caucasian Populations.
(799)
RM Elliott, MA Leversha, JM Satagopan, QC Zhou, M Dudas, Y-B Chen, H Al-Ahmadie, S Fine, S Tickoo, JA Eastham, PT Scardino, M Koscuiszka, P Lee, I Osman, WL Gerald, VE Reuter, A Gopalan - Memorial Sloan-Kettering Cancer Center, New York; New York University, NY
ERG, TMPRSS2 and SLC45A3 Expression in Prostate Cancers with Rearrangements of these Genes.
(931)
NJ Rupp, S Perner, M Braun, H Moch, F Fend, MA Rubin, G Kristiansen - University Hospital Bonn, Germany; University Hospital Zurich, Switzerland; University Hospital Tubingen, Germany; Weill Cornell Medical College, New York, NY
TMPRSS2:ERG Rearrangement and Markers of Metabolic Signaling Pathways Implicated in Prostate Carcinogenesis.
(917)
A Pettersson, R Flavin, J Stark, M Fiorentino, M Pollak, K Penney, HD Sesso, M Gleave, TA Bismar, S Perner, S Finn, MA Rubin, J Ma, E Giovannucci, M Stampfer, P Kantoff, M Loda, L Mucci - Dana Farber/Harvard Cancer Center, Boston, MA
ERG Rearrangement Status in Prostate Cancer Detected by Immunohistochemistry.
(804)
SM Falzarano, M Zhou, P Carver, H He, C Magi-Galluzzi - Cleveland Clinic
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer.
(910)
K Park, SA Tomlins, KM Mudaliar, Y-L Chiu, R Esgueva, R Mehra, K Suleman, S Varambally, JC Brenner, T MacDonald, A Srivastava, AK Tewari, U Sathyanarayana, D Nagy, G Pestano, LP Kunju, F Demichelis, AM Chinnaiyan, MA Rubin - Weill Cornell Medical College, New York, NY; University of Michigan, Ann Arbor; Roche Group, Tucson, AZ
Characterization of Complex Chromosomal Aberrations in Primary Prostate Cancer Genomes.
(752)
MF Berger, MS Lawrence, F Demichelis, G Getz, MA Rubin, LA Garraway, For the Broad Institute and Weill Cornell Medical College Prostate Genome Consortium - The Broad Institute, Cambridge; Weill Cornell Medical College, New York; Harvard Medical School, Boston; Dana-Farber Cancer Institute, Boston
Diagnostic Value of ERG Oncoprotein Detection in Biopsy Specimens.
(932)
D Russell, GL Lee, P Parker, B Furusato, DY Young, Y Chen, T Sreenath, A Dobi, DG Mcleod, S Srivastava, IA Sesterhenn, JT Moncur - Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD; Armed Forces Institute of Pathology, Washington, DC; Walter Reed Army Medical Center, Washington, DC
The Utility of Novel ERG/P63 Cocktail in the Diagnosis of Limited Cancer in Prostate Needle Biopsies.
(978)
O Yaskiv, K Simmerman, S Zhang, T Daly, H He, S Falzarano, L Chen, C Magi-Galluzzi, M Zhou - Cleveland Clinic, OH
Clinicopathological Correlation of ERG Protein Expression in Single Focus Prostate Cancer.
(941)
IA Sesterhenn, S-H Tan, A Dobi, S Srivastava, DG McLeod, SA Brassell, B Furusato - Armed Forces Institute of Pathology, Washington, DC; Uniformed Services University of the Health Sciences, Bethesda, MD; Walter Reed Army Medical Center, Washington, DC
Characterization of ERG Gene Rearrangements and PTEN Deletions in Unsuspected Prostate Cancer of the Transition Zone.
(878)
S Liu, M Yoshimoto, K Trpkov, JA Squire, Q Duan, TA Bismar - Univerity of Calgary and Calgary Laboratory Services, AB, Canada; Kingston General Hospital and Queen's University, AB, Canada; Tom Baker Cancer Center, Calgary, AB, Canada
Gleason Score (GS) 7 Prostate Cancer with Lymph Node Metastases (LN+): Findings at Radical Prostatectomy (RP).
(862)
ON Kryvenko, NS Gupta, N Virani, Z Lane, JI Epstein - Henry Ford Hospital, Detroit; Jefferson Medical College, Philadelphia; Johns Hopkins University, Baltimore
Assessment of Tumor Volume by Frozen Section Examination of the Radical Prostatectomy Specimen: Correlation with Long-Term Follow-Up.
(847)
RE Jimenez, JC Cheville, RJ Karnes, JL Hilderbrand, CM Lohse, TJ Sebo - Mayo Clinic, Rochester, MN
Automated Tumor Volume Estimation Using Digitized Prostatectomy Specimens.
(894)
JP Monaco, JE Tomaszewski, A Madabhushi - Rutgers University, Piscataway, NJ; University of Pennsylvania, Philadelphia
Comparative Study of 3.0T MRI and Whole-Mount Prostatectomy Sections for Prostate Cancer Detection.
(814)
LV Furtado, M Heilbrun, C Dechet, M Schabel, B Foster, LJ Layfield, T Liu - University of Utah Health Sciences Center, Salt Lake City
Assessment of the Aggressivenss of Ductal Adenocarcinoma (Adenoca) of the Prostate: A Radical Prostatectomy (RP) Study of 93 Cases.
(740)
A Amin, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD
Pathological Features of Contemporary Radical Prostatectomy Specimens for Prostate Cancer.
(881)
C Magi-Galluzzi, SM Falzarano, K Streator Smith, EA Klein, M Zhou - Cleveland Clinic
Expression of Seminal Plasma Proteins in Prostate Cancer: Prognostic Implications after Radical Prostatectomy.
(765)
AM Canacci, K Izumi, Y Zheng, J Gordetsky, JL Yao, H Miyamoto - University of Rochester, NY
Frozen Section (FS) Evaluation of Margins in Radical Prostatectomy Specimens.
(904)
A Nunez, F Mukhtar, V Dailey, R El-Galley, O Hameed - University of Alabama at Birmingham
Focal and Diffuse Positive Surgical Margins in Radical Prostatectomies (RP): How Should Be Quantitated?
(757)
A Billis, L Meirelles, LLL Freitas, AGE Duarte, CAM Silva, MAM Busson, LA Magna, LO Reis, U Ferreira - School of Medicine, University of Campinas (Unicamp), SP, Brazil; School of Medicine, University of Campinas, Unicamp, SP, Brazil
Prognostic Impact of Subclassification of Radical Prostatectomy Positive Margins by Linear Extent and Gleason Grade.
(808)
SW Fine, K Udo, AM Cronin, LJ Carlino, HA Al-Ahmadie, A Gopalan, SK Tickoo, PT Scardino, JA Eastham, VE Reuter - Memorial Sloan-Kettering Cancer Center, NY
Do Benign Glands at the Resection Margin Increase the Risk of Biochemical Failure Post Radical Prostatectomy?
(769)
SM Chan, FJ Garcia, MS Moussa, JL Chin, MY Gabril - London Health Sciences Center/University of Western Ontario, ON, Canada; Division of Urology, London Health Sciences Center/ University of Western Ontario, London, ON, Canada
Pitfalls in Using High Molecular Weight Cytokeratin 34BE12 (CK903) and P63/Racemase Staining To Evaulate Cauterized Glands at the Margin in Radical Prostatectomy.
(767)
D Cao, P Humphrey - Washington University School of Medicine, St. Louis
Effect of Robotic-Assisted Laparoscopic Prostatectomy on Surgical Pathology Specimens.
(835)
H Hong, L Mel, J Taylor, Q Wu, H Reeves, A Allan - Brody School of Medicine at East Carolina University, Greenville, NC; Eastern Urological Associates, P.A., Greenville, NC; College of Allied Health Sciences at East Carolina University, Greenville, NC
Total Submission of Pelvic Lymphadenectomies Performed at Radical Prostatectomy Increases Lymph Node Yields and Detection of Microscopic Metastases.
(914)
JL Perry-Keene, H Samaratunga, V Vyas, B Delahunt - Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Aquesta Pathology, Brisbane, QLD, Australia; Wellington School of Medicine and Health Science, University of Otago, Wellington, New Zealand
The Role of Periprostatic and Periseminal Vesicle Lymph Node Metastasis in the Staging and Prognosis of Prostate Cancer.
(955)
MK Subik, JL Yao, PA di Sant'Agnese, H Miyamoto - University of Rochester, NY
Periprostatic Lymph Node Metastasis in Prostate Cancer and Its Clinical Significance.
(789)
F-M Deng, SE Mendrinos, K Das, J Melamed - New York University Medical Center, NY
Nodal Yield, Size and Distribution of Pelvic Lymph Node Metastases in Prostatic Adenocarcinoma: A Study of 72 Cases.
(980)
J Yoon, O Kryvenko, S Kaul, N Patil, N Gupta - Henry Ford Hospital, Detroit, MI
Anterior Fat Pad Lymph Node Evaluation in Robot-Assisted Radical Prostatectomy (RARP) Specimens.
(850)
SH Kang, HS Hwang, SH Yoo, DS Yoo, H Ahn, YM Cho, E McQuitty, JY Ro - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX
Do Robotic Prostatectomy Positive Surgical Margins Occur in the Same Location as Extraprostatic Extension?
(848)
MT Johnson, GN Box, DS Sharp, A Shabsigh, R Abaza, DL Zynger - The Ohio State University Medical Center, Columbus
Histopathologic Correlation of Prostatic Adenocarcinoma on Radical Prostatectomy with Pre-Operative Anti-18F Fluorocyclobutyl-Carboxylic Acid Positron Emission Tomography/Computed Tomography.
(939)
D Schuster, B Fei, T Fox, AO Osunkoya - Emory University School of Medicine, Atlanta
A Retrospective Study on Pathologic Features and Racial Disparities in Prostate Cancer.
(756)
SA Bigler, X Zhou - University of Mississippi Medical Center, Jackson
microRNA Associated with Aggressive Prostate Cancer in Racial Disparity.
(839)
H Huang, X Wu, L Zhou, Y Li, O Basturk, H Ostrer, S Freedland, I Osman, V Reuter, J Melamed, P Lee - New York University Medical Center, NY; Memorial Sloan Kettering Cancer Center, New York, NY
The Novel Vitamin D Analog ZK 191784 Inhibits Prostate Cancer Cell Invasion by Modulating Matrix Metalloproteinases and the Adhesion Molecule ICAM-1.
(899)
G Nesi, M Martinesi, C Treves, A Simoni, M Stio - University of Florence, Italy
Semaphorin 4F Expression and Its Role in Axonogenesis and Aggressive Behavior of Prostate Cancer.
(907)
A Olar, R Le, Y Ding, D He, D Florentin, G Ayala - Baylor College of Medicine, Houston, TX
Biologic Significance of Axonogenesis in Prostate Cancer Measured by PGP 9.5.
(906)
A Olar, R Li, D He, D Florentin, G Ayala - Baylor College of Medicine, Houston, TX
Molecular Diagnosis of Prostate Cancer from Biopsy Needles Surplus Material.
(753)
R Bermudo, TM Thomson, D Abia, A Mozos, E Garcia, A Alcaraz, PL Fernandez - Hospital Clinic-IDIBAPS, Barcelona, Spain; Hospital Clinic, Barcelona, Spain; Instituto de Biologia Molecular,CSIC, Barcelona, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Biologia Molecular Severo Ochoa,CSIC, Madrid, Spain
Regional Variation in Epigenetic Patterns in Prostate Cancer.
(739)
FZ Aly, JC Hanson, W Yang, MS Kreitman, MJ Merino, MW Linehan, PA Pinto, LG Adams, HS Stevenson, DC Edelman, MR Emmert-Buck, J Rodriguez-Canales - National Cancer Institute, Bethesda, MD
Prostatic Diseases in the Elderly Men: Glandular Microenvironment Signaling of IGFR-1, Steroid Hormone Receptors, Matrix Metalloproteinases and Dystroglycans.
(834)
A Hetzl, W Favaro, F Montico, U Ferreira, A Billis, V Cagnon - UNICAMP/Institute of Biology, Campinas, Sao Paulo, Brazil; UNESP, Campinas, Sao Paulo, Brazil; UNICAMP, Campinas, Sao Paulo, Brazil
Differential Expression of UBE2C and ASCL1 in Neuroendocrine Carcinoma and Adenocarcinoma of the Prostate in Xenograft Models and Human Samples.
(964)
V Tzelepi, S Maity, J Zhang, M Karlou, S Liang, A Hoang, J-F Lu, B Kleb, E Efstathiou, N Navone, A Aparicio, P Troncoso - UT MD Anderson Cancer Center, Houston, TX
Fine Needle Aspiration (FNA) Cytology of Metastatic Prostate Carcinoma. Is Cytoplasmic Vacuolization a Morphologic Feature of Anti-Androgen Effect and an Aid in the Differential Diagnosis?
(802)
CL Ellis, QK Li - The Johns Hopkins Hospital, Baltimore, MD
Oxidative Damage Sensor in Atrophy and Adenocarcinoma in the Prostate.
(892)
AP Mogal, MA Watson, PA Humphrey - Washington University School of Medicine, St. Louis, MO
Evaluation of the Epithelial Component of Stromal Tumor of Uncertain Malignant Potential (STUMP).
(898)
M Nagar, J Epstein - The Johns Hopkins Hospital, Baltimore, MD
Under-Expression of Nuclear Matrix Protein Sp100: A Basis for Why Prostate Cancer Nuclei Look Different Than Benign Nuclei.
(962)
LD True, I Coleman, D Gifford, R Coleman, P Nelson - University of Washington, Seattle; Fred Hutchinson Cancer Research Center, Seattle
The Lymphoma-Associated EZH2 Codon 641 Mutation Is Not Detected in Localized Prostate Carcinoma.
(933)
RJ Ryan, S Wu, D Borger, J Iafrate, C-L Wu, L Le - Massachusetts General Hospital, Boston
Increased Phosphorylated 4EBP1 Expression in Minute Prostatic Adnocarcinoma.
(733)
R Albadine, A Chaux, J Hicks, AM De Marzo, GJ Netto - Johns Hopkins Medical Institution, Baltimore
Focal Positive PSMA Expression in Ganglionic Tissues Associated with Prostate Neurovascular Bundle: Implications for Novel Intraoperative PSMA Based Fluorescent Imaging Techniques.
(806)
SF Faraj, J Solus, J Eifler, T Alhussain, A Chaux, M Pomper, R Rodriguez, GJ Netto - Johns Hopkins Medical Institution, Baltimore, MD
Mesonephric Remnant Hyperplasia Involving the Prostate and Periprostatic Tissue: Findings at Radical Prostatectomy (RP).
(775)
Y-B Chen, S Fine, JI Epstein - Memorial Sloan-Kettering Cancer Center, New York; The Johns Hopkins Hospital, Baltimore
ERG Protein Expression in Prostatic Small Cell Carcinoma Cases with Known ERG Gene Rearrangement Status.
(879)
T Lotan, A Chaux, W Wang, N Gupta, J Epstein, A De Marzo, G Netto - Johns Hopkins University School of Medicine, Baltimore, MD
ERG-TMPRSS2 Rearrangement Is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder.
(975)
SR Williamson, S Zhang, JL Yao, J Huang, A Lopez-Beltran, S Shen, AO Osunkoya, GT MacLennan, R Montironi, L Cheng - Indiana University, Indianapolis; University of Rochester; University of California at Los Angeles; Cordoba University, Spain; The Methodist Hospital, Houston; Emory University, Atlanta; Case Western Reserve University, Cleveland; Polytechnic University of the Marche Region, Ancona, Italy
Discovery of Novel Drug Targets for Small Cell Prostate Cancer.
(911)
K Park, H Beltran, D Rickman, TY MacDonald, S Terry, F Demichelis, DM Nanus, MA Rubin - Weill Cornell Medical College, New York
Rb, PTEN and p53 Tumor Suppressor Loss Is Common in Prostatic Small Cell Carcinoma.
(922)
H Rahimi, W Wang, NS Gupta, JI Epstein, GJ Netto, AM De Marzo, TL Lotan - Johns Hopkins University School of Medicine, Baltimore, MD; Henry Ford Health System, Detroit, MI
Comedonecrosis Revisited: Assocations with Intraductal Carcinoma of the Prostate.
(807)
SW Fine, K Udo, HA Al-Ahmadie, Y-B Chen, A Gopalan, SK Tickoo, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York, NY
Concomitant ERBB2-ERBB3 Expression in Prostatic Large Duct Carcinoma.
(935)
MA Salomao, L Araujo, M Mansukhani, MJ Szabolcs - Columbia University Medical Center, New York, NY
Immunohistochemical Expression of Prostate-Specific Antigen (PSA), Prostatic Acid Phosphatase (PAP) and Antibody Cocktail (P63/HMWCK/AMACR) in Ductal Adenocarcinoma of the Prostate.
(936)
H Samaratunga, M Adamson, J Yaxley, B Delahunt - Aquesta Pathology, Brisbane, QLD, Australia; University of Queensland, Brisbane, Australia; Royal Brisbane Hospital, Brisbane, QLD, Australia; University of Otago, Wellington, New Zealand
Atypical Prostatic Ductal Lesions (APDL) Presenting as Small Prostatic Urethral Polyps: A Clinicopathologic Study of 7 Cases and Documentation of a Unique form of Prostatic Ductal Neoplasia Warranting Active Surveillance.
(744)
C Annaiah, BL Balzer, RS Parakh, LP Herrera, K Arora, DJ Luthringer, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA
Subcellular Localization and Quantification of Androgen Receptor in Hormone-Naive Prostatic Adenocarcinoma and Clinical Correlation.
(838)
W Huang, C Hoyt, T Pier, D Fletcher-Holmes - University of Wisconsin-Madison; Cambridge Research and Instrumentation, Inc., Woburn, MA
FOXA1 a Poor Prognostic Marker in Prostate Cancer: A Validation Study.
(845)
RK Jain, R Mehta, J Ro, H Nakshatri, YM Cho, S Badve - Indiana University School of Medicine, Indianapolis; Methodist Hospital, Houston, TX; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Expression of the Hedgehog Family of Proteins in Prostatic Adenocarcinomas (PACS): Hedgehog Signaling Is Associated with High Grade, Advanced Stage and Biochemical Disease Recurrence.
(849)
BVS Kallakury, GM Sheehan, CE Sheehan, HAG Fisher, RP Kaufman, T Nazeer, JS Ross - Georgetown Univ Hospital, Washington, DC; Albany Medical College, NY
NKX3.1, PTEN, ERG and AR Define Genetic Alteration Patterns Correlating with Tumor Progression in Prostate Cancer.
(938)
V Scheble, G Scharf, R Menon, P Nikolov, K Petersen, F Fend, M Reischl, S Perner - University Hospital Tuebingen, Germany; Karlsruhe Institute of Technology, Germany
SPINK1 Protein Expression and Prostate Cancer Progression.
(810)
R Flavin, W Hendrickson, L Krunz, G Judson, R Lis, D Bailey, M Fiorentino, S Finn, N Martin, J Stark, A Pettersson, J Sinnott, K Penny, K Fall, E Giovannucci, M Rubin, P Kantoff, M Stampfer, M Loda, L Mucci - Dana Farber Cancer Institute/Harvard Cancer Center, Boston; Weill Cornell Medical College, New York
button next to any title to add to Itinerary Planner...
Add
